Liraglutide

Liraglutide is a medication utilised to manage type 2 diabetes and obesity. It emulates the function of a hormone called glucagon-like peptide-1 (GLP-1), which aids in regulating blood sugar levels and appetite. By stimulating GLP-1 receptors, liraglutide prompts insulin secretion, retards gastric emptying, and fosters sensations of satiety, thereby enhancing glycemic control and facilitating weight reduction. Administered via injection, liraglutide has demonstrated notable efficacy in reducing blood sugar levels and fostering weight loss in clinical trials. However, akin to any medication, it may entail side effects, such as nausea, abdominal cramps and diarrhoea, necessitating discussion with a healthcare professional.